How we manage idiopathic multicentric Castleman disease
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
|---|---|
| Enthalten in: |
Clinical advances in hematology & oncology : H&O - 20(2022), 9 vom: 16. Sept., Seite 564-571 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Brandstadter, Joshua D [VerfasserIn] |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 23.09.2022 Date Revised 01.11.2022 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM346424216 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM346424216 | ||
| 003 | DE-627 | ||
| 005 | 20231226031423.0 | ||
| 007 | tu | ||
| 008 | 231226s2022 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n1154.xml |
| 035 | |a (DE-627)NLM346424216 | ||
| 035 | |a (NLM)36125948 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Brandstadter, Joshua D |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a How we manage idiopathic multicentric Castleman disease |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 23.09.2022 | ||
| 500 | |a Date Revised 01.11.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Fajgenbaum, David C |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical advances in hematology & oncology : H&O |d 2003 |g 20(2022), 9 vom: 16. Sept., Seite 564-571 |w (DE-627)NLM157777022 |x 1543-0790 |7 nnns |
| 773 | 1 | 8 | |g volume:20 |g year:2022 |g number:9 |g day:16 |g month:09 |g pages:564-571 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 20 |j 2022 |e 9 |b 16 |c 09 |h 564-571 | ||